← Screener

Health care · Biotechnology · Nasdaq

GILDGilead Sciences

Compare with peers → Embed

Where it stands

GILD among the 60 companies we cover

All 60 →

Every dot is one of the 60 companies, the better end on the right. Hover a dot for the company.

Sales growth

+2.4%47th of 60 · median +7.1%

Net margin

-12.5%59th of 60 · median 9.6%

Return on equity

-29.6%53rd of 54 · median 13.1%

Free cash flow margin

44.5%1st of 56 · median 15.5%

Debt / equity (less is better)

2.0145th of 49 · median 0.66

GILD and 9 peers, year by year

The 9 Health care companies closest to GILD in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
GILD Gilead Sciences	FY2025	$29.4B	+2.4%	-	34.0%	28.9%	32.1%	37.5%	1.10
SYK Stryker Corporation	FY2025	$25.1B	+11.2%	64.0%	19.5%	12.9%	17.1%	14.5%	0.66
DHR Danaher Corporation	FY2025	$24.6B	+2.9%	59.1%	19.1%	14.7%	21.4%	6.9%	0.35
MDT Medtronic	FY2026	$36.4B	+8.4%	-	17.8%	13.2%	14.9%	9.7%	0.57
AMGN Amgen	FY2025	$36.8B	+10.0%	-	24.7%	21.0%	22.0%	89.1%	6.31
BDX Becton Dickinson	FY2025	$21.8B	+8.2%	-	11.8%	7.7%	12.2%	6.6%	0.76
GEHC GE HealthCare	FY2025	$20.6B	+4.8%	40.0%	13.4%	10.1%	7.3%	20.1%	1.01
BSX Boston Scientific	FY2025	$20.1B	+19.9%	69.0%	18.0%	14.4%	18.2%	12.0%	0.47
UHS Universal Health Services	FY2025	$17.4B	+9.7%	-	11.5%	8.6%	4.9%	20.5%	0.66
IQV IQVIA	FY2025	$16.3B	+5.9%	-	13.4%	8.3%	12.6%	20.9%	2.42

Revenuepeer median $21.8B

Sales growthpeer median +8.4%

Gross marginpeer median 61.5%

BSX 69.0%
SYK 64.0%
DHR 59.1%
GEHC 40.0%
GILD -
MDT -
AMGN -
BDX -
UHS -
IQV -

Operating marginpeer median 17.8%

Net marginpeer median 12.9%

FCF marginpeer median 14.9%

Return on equitypeer median 14.5%

Debt / equitypeer median 0.66

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	$30.4B	$26.1B	$22.1B	$22.4B	$24.7B	$27.3B	$27.3B	$27.1B	$28.8B	$29.4B
SYK Dec	$11.3B	$12.4B	$13.6B	$14.9B	$14.4B	$17.1B	$18.4B	$20.5B	$22.6B	$25.1B
DHR Dec	$16.9B	$18.3B	$19.9B	$17.9B	$22.3B	$24.8B	$26.6B	$23.9B	$23.9B	$24.6B
MDT Apr	$28.8B	$29.7B	$30.0B	$30.6B	$28.9B	$30.1B	$31.7B	$31.2B	$32.4B	$33.5B
AMGN Dec	$23.0B	$22.8B	$23.7B	$23.4B	$25.4B	$26.0B	$26.3B	$28.2B	$33.4B	$36.8B
BDX Sep	$12.5B	$12.1B	$16.0B	$17.3B	$16.1B	$19.1B	$18.9B	$19.4B	$20.2B	$21.8B
GEHC Dec	-	-	-	-	-	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
BSX Dec	$9.1B	$9.0B	$9.8B	$10.7B	$9.9B	$11.9B	$12.7B	$14.2B	$16.7B	$20.1B
UHS Dec	$9.8B	$10.4B	$10.8B	$11.4B	$11.6B	$12.6B	$13.4B	$14.3B	$15.8B	$17.4B
IQV Dec	$6.9B	$9.7B	$10.4B	$11.1B	$11.4B	$13.9B	$14.4B	$15.0B	$15.4B	$16.3B
Peer median	$11.9B	$12.3B	$14.8B	$16.1B	$15.2B	$17.6B	$18.4B	$19.6B	$20.2B	$21.8B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	−6.9%	−14.1%	−15.2%	+1.5%	+10.0%	+10.6%	−0.1%	−0.6%	+6.0%	+2.4%
SYK Dec	+13.9%	+9.9%	+9.3%	+9.4%	−3.6%	+19.2%	+7.8%	+11.1%	+10.2%	+11.2%
DHR Dec	+17.0%	+8.6%	+9.9%	+5.1%	+24.4%	+32.2%	+7.4%	−10.3%	−0.1%	+2.9%
MDT Apr	-	+3.0%	+0.8%	+2.0%	−5.4%	+4.2%	+5.2%	−1.4%	+3.6%	+3.6%
AMGN Dec	+6.1%	−0.6%	+3.9%	−1.6%	+8.8%	+2.2%	+1.3%	+7.1%	+18.6%	+10.0%
BDX Sep	+21.4%	−3.1%	+32.2%	+8.2%	−1.0%	+19.0%	−1.4%	+2.7%	+4.2%	+8.2%
GEHC Dec	-	-	-	-	-	-	+4.3%	+6.6%	+0.6%	+4.8%
BSX Dec	+12.2%	+7.9%	+8.6%	+9.3%	−7.7%	+19.9%	+6.7%	+12.3%	+17.6%	+19.9%
UHS Dec	+8.0%	+6.6%	+3.5%	+5.6%	+1.6%	+9.4%	+6.0%	+6.6%	+10.8%	+9.7%
IQV Dec	+19.9%	+42.4%	+7.3%	+6.5%	+2.4%	+22.1%	+3.9%	+4.0%	+2.8%	+5.9%
Peer median	+13.9%	+7.2%	+7.9%	+6.1%	+0.3%	+19.1%	+5.2%	+6.6%	+4.2%	+8.2%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	-	-	-	-	-	-	-	-	-	-
SYK Dec	66.3%	65.7%	65.7%	65.1%	63.1%	64.1%	62.8%	63.7%	63.9%	64.0%
DHR Dec	55.3%	46.8%	47.8%	55.7%	56.0%	61.4%	60.8%	58.7%	59.5%	59.1%
MDT Apr	68.3%	68.7%	69.8%	-	-	-	-	-	-	-
AMGN Dec	-	-	-	-	-	-	-	-	-	-
BDX Sep	48.0%	49.1%	45.5%	47.9%	47.1%	-	-	-	-	-
GEHC Dec	-	-	-	-	-	40.8%	39.1%	40.5%	41.7%	40.0%
BSX Dec	65.7%	71.3%	71.4%	71.0%	65.0%	68.8%	68.8%	69.5%	68.6%	69.0%
UHS Dec	-	-	-	-	-	-	-	-	-	-
IQV Dec	-	-	-	-	-	-	-	-	-	-
Peer median	65.7%	65.7%	65.7%	60.4%	59.5%	62.8%	61.8%	61.2%	61.7%	61.5%

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	58.0%	54.1%	37.1%	19.1%	16.5%	36.3%	26.9%	28.0%	5.8%	34.0%
SYK Dec	19.2%	18.5%	18.7%	18.2%	15.5%	15.1%	15.4%	19.0%	16.3%	19.5%
DHR Dec	16.2%	14.0%	15.4%	18.3%	19.0%	25.7%	28.3%	21.8%	20.4%	19.1%
MDT Apr	18.6%	18.1%	22.2%	20.5%	16.6%	14.9%	18.2%	17.6%	15.9%	17.8%
AMGN Dec	42.6%	43.6%	43.2%	41.4%	35.9%	29.4%	36.3%	28.0%	21.7%	24.7%
BDX Sep	11.5%	12.6%	9.4%	10.2%	5.7%	11.8%	12.1%	10.9%	11.9%	11.8%
GEHC Dec	-	-	-	-	-	15.9%	13.8%	12.5%	13.3%	13.4%
BSX Dec	4.9%	14.2%	15.3%	14.1%	−0.8%	10.1%	13.0%	16.5%	15.5%	18.0%
UHS Dec	13.1%	12.3%	10.9%	10.7%	11.8%	10.8%	7.5%	8.2%	10.6%	11.5%
IQV Dec	8.4%	6.8%	7.1%	7.0%	6.4%	10.0%	12.5%	13.2%	14.3%	13.4%
Peer median	14.7%	14.1%	15.3%	16.2%	13.6%	14.9%	13.8%	16.5%	15.5%	17.8%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	44.4%	17.7%	24.7%	24.0%	0.5%	22.8%	16.8%	20.9%	1.7%	28.9%
SYK Dec	14.5%	8.2%	26.1%	14.0%	11.1%	11.7%	12.8%	15.4%	13.2%	12.9%
DHR Dec	15.1%	13.6%	13.3%	16.8%	16.4%	25.9%	27.1%	19.9%	16.3%	14.7%
MDT Apr	12.3%	13.6%	10.4%	15.2%	16.6%	12.0%	15.9%	12.0%	11.4%	13.9%
AMGN Dec	33.6%	8.7%	35.3%	33.6%	28.6%	22.7%	24.9%	23.8%	12.2%	21.0%
BDX Sep	7.8%	9.1%	1.9%	7.1%	5.4%	10.9%	9.4%	7.7%	8.4%	7.7%
GEHC Dec	-	-	-	-	-	12.8%	10.4%	8.0%	10.1%	10.1%
BSX Dec	3.8%	1.1%	17.0%	43.8%	−1.2%	8.3%	5.1%	11.0%	11.1%	14.4%
UHS Dec	7.2%	7.2%	7.2%	7.2%	8.2%	7.8%	5.0%	5.0%	7.2%	8.6%
IQV Dec	1.0%	13.1%	2.5%	1.7%	2.5%	7.0%	7.6%	9.1%	8.9%	8.3%
Peer median	10.0%	8.9%	11.8%	14.6%	9.7%	11.7%	10.4%	11.0%	11.1%	12.9%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	$16.3B	$11.3B	$7.5B	$8.3B	$7.5B	$10.8B	$8.3B	$7.4B	$10.3B	$9.5B
SYK Dec	$1.4B	$961.0M	$2.0B	$1.5B	$2.8B	$2.7B	$2.0B	$3.1B	$3.5B	$4.3B
DHR Dec	$2.9B	$2.9B	$3.4B	$3.3B	$5.4B	$7.1B	$7.4B	$5.8B	$5.3B	$5.3B
MDT Apr	$4.2B	$5.6B	$3.6B	$5.9B	$6.0B	$4.9B	$6.0B	$4.6B	$5.2B	$5.2B
AMGN Dec	$9.6B	$10.5B	$10.6B	$8.5B	$9.9B	$8.4B	$8.8B	$7.4B	$10.4B	$8.1B
BDX Sep	$1.9B	$1.8B	$2.0B	$2.4B	$2.8B	$3.5B	$1.5B	$2.1B	$3.1B	$2.7B
GEHC Dec	-	-	-	-	-	$1.4B	$1.8B	$1.7B	$1.6B	$1.5B
BSX Dec	$806.0M	$1.1B	−$6.0M	$1.4B	$1.1B	$1.3B	$938.0M	$1.8B	$2.6B	$3.7B
UHS Dec	$813.9M	$690.1M	$609.8M	$804.4M	$1.6B	$28.0M	$262.0M	$524.7M	$1.1B	$849.2M
IQV Dec	$696.0M	$601.0M	$795.0M	$835.0M	$1.3B	$2.3B	$1.6B	$1.5B	$2.1B	$2.1B
Peer median	$1.6B	$1.5B	$2.0B	$2.0B	$2.8B	$2.7B	$1.8B	$2.1B	$3.1B	$3.7B

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	53.6%	43.3%	33.8%	37.1%	30.5%	39.6%	30.6%	27.4%	35.8%	32.1%
SYK Dec	12.6%	7.7%	15.0%	10.4%	19.4%	16.0%	11.0%	15.3%	15.4%	17.1%
DHR Dec	17.4%	15.9%	17.3%	18.5%	24.3%	28.7%	27.8%	24.2%	22.2%	21.4%
MDT Apr	14.5%	18.9%	12.1%	19.2%	20.8%	16.2%	18.9%	14.7%	16.1%	15.5%
AMGN Dec	41.8%	46.0%	44.5%	36.5%	38.9%	32.3%	33.4%	26.1%	31.1%	22.0%
BDX Sep	14.9%	15.1%	12.3%	13.7%	17.2%	18.0%	7.9%	10.9%	15.5%	12.2%
GEHC Dec	-	-	-	-	-	7.7%	9.9%	8.8%	7.9%	7.3%
BSX Dec	8.9%	12.2%	−0.1%	12.8%	11.4%	11.1%	7.4%	12.6%	15.8%	18.2%
UHS Dec	8.3%	6.6%	5.7%	7.1%	14.1%	0.2%	2.0%	3.7%	7.1%	4.9%
IQV Dec	10.1%	6.2%	7.6%	7.5%	11.8%	16.6%	11.0%	10.0%	13.7%	12.6%
Peer median	13.5%	13.7%	12.2%	13.3%	18.3%	16.2%	11.0%	12.6%	15.5%	15.5%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	71.5%	22.6%	25.5%	23.9%	0.7%	29.5%	21.6%	24.8%	2.5%	37.5%
SYK Dec	17.2%	10.2%	30.3%	16.3%	12.2%	13.4%	14.2%	17.0%	14.5%	14.5%
DHR Dec	11.1%	9.5%	9.4%	9.9%	9.2%	14.2%	14.4%	8.9%	7.9%	6.9%
MDT Apr	6.8%	8.0%	6.1%	9.2%	9.4%	7.0%	9.6%	7.3%	7.3%	9.7%
AMGN Dec	25.8%	7.8%	67.2%	81.1%	77.2%	88.0%	179.0%	107.8%	69.6%	89.1%
BDX Sep	12.8%	8.5%	1.5%	5.8%	3.7%	8.8%	7.0%	5.8%	6.6%	6.6%
GEHC Dec	-	-	-	-	-	13.5%	20.5%	22.0%	23.6%	20.1%
BSX Dec	5.2%	1.5%	19.1%	33.9%	−0.8%	5.9%	3.7%	8.1%	8.5%	12.0%
UHS Dec	15.5%	15.1%	14.5%	14.8%	14.9%	16.3%	11.4%	11.7%	17.1%	20.5%
IQV Dec	0.8%	16.0%	3.9%	3.2%	4.6%	16.0%	18.9%	22.2%	22.6%	20.9%
Peer median	11.9%	9.0%	11.9%	12.4%	9.3%	13.5%	14.2%	11.7%	14.5%	14.5%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	1.39	1.64	1.28	1.09	1.73	1.27	1.19	1.09	1.38	1.10
SYK Dec	0.72	0.66	0.72	0.80	1.01	0.84	0.71	0.59	0.59	0.66
DHR Dec	0.65	0.41	0.35	0.72	0.53	0.49	0.40	0.38	0.33	0.35
MDT Apr	0.60	0.67	0.51	0.51	0.49	0.51	0.46	0.47	0.50	0.53
AMGN Dec	1.16	1.40	2.71	3.09	3.51	4.97	10.64	10.37	10.23	6.31
BDX Sep	1.51	1.46	1.02	0.92	0.75	0.74	0.64	0.62	0.78	0.76
GEHC Dec	-	-	-	-	-	-	0.88	1.46	1.24	1.01
BSX Dec	0.80	0.80	0.81	0.72	0.60	0.55	0.51	0.47	0.49	0.47
UHS Dec	0.91	0.81	0.74	0.72	0.61	0.69	0.81	0.80	0.68	0.66
IQV Dec	0.84	1.28	1.64	1.94	2.09	2.01	2.21	2.24	2.30	2.42
Peer median	0.82	0.81	0.78	0.76	0.68	0.72	0.71	0.62	0.68	0.66

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
GILD Dec	$9.94	$3.51	$4.17	$4.22	$0.10	$4.93	$3.64	$4.50	$0.38	$6.78
SYK Dec	$4.35	$2.68	$9.34	$5.48	$4.20	$5.21	$6.17	$8.25	$7.76	$8.40
DHR Dec	$3.65	$3.53	$3.74	$4.05	$4.89	$8.61	$9.66	$6.38	$5.29	$5.05
MDT Apr	$2.48	$2.89	$2.27	$3.41	$3.54	$2.66	$3.73	$2.82	$2.76	$3.61
AMGN Dec	$10.24	$2.69	$12.62	$12.88	$12.31	$10.28	$12.11	$12.49	$7.56	$14.23
BDX Sep	$4.49	$4.60	$0.60	$3.94	$2.71	$6.85	$5.88	$4.94	$5.86	$5.82
GEHC Dec	-	-	-	-	-	$4.95	$4.22	$3.03	$4.34	$4.55
BSX Dec	$0.25	$0.08	$1.19	$3.33	−$0.08	$0.69	$0.45	$1.07	$1.25	$1.94
UHS Dec	$7.14	$7.81	$8.31	$9.13	$10.99	$11.82	$9.14	$10.23	$16.82	$23.10
IQV Dec	$0.47	$5.74	$1.24	$0.96	$1.43	$4.95	$5.72	$7.29	$7.49	$7.84
Peer median	$4.00	$3.21	$3.00	$4.00	$3.87	$5.21	$5.88	$6.38	$5.86	$5.82

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out GILD and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on GILD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GILD/export.csv") into a cell.